Coeptis Therapeutics Holdings, Inc.
COEP
$9.67
-$0.08-0.82%
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Net Income | 39.75% | -1.13% | 20.08% | 40.86% | -98.29% |
| Total Depreciation and Amortization | 11.19% | 0.00% | -0.04% | -10.77% | 12.07% |
| Total Amortization of Deferred Charges | -- | -100.00% | -- | -- | -- |
| Total Other Non-Cash Items | -114.54% | 128.21% | -32.32% | -76.64% | 415.56% |
| Change in Net Operating Assets | -378.62% | -133.37% | -90.42% | 276.79% | -19.36% |
| Cash from Operations | -33.50% | 25.48% | -12.32% | 13.51% | -2.92% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | 100.00% | -- | -- | 200.00% |
| Cash from Investing | -- | 100.00% | -- | -- | 200.00% |
| Total Debt Issued | -100.00% | -62.96% | 800.00% | 105.19% | -185.25% |
| Total Debt Repaid | 100.00% | -4.35% | 17.86% | 60.00% | -- |
| Issuance of Common Stock | -- | -- | -71.45% | -50.54% | -- |
| Repurchase of Common Stock | 88.89% | -- | -- | -- | -- |
| Issuance of Preferred Stock | -9.96% | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -100.00% | -- | -- | -- | -- |
| Cash from Financing | -24.11% | 24.39% | -10.79% | 878.75% | -106.63% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -179.42% | 219.53% | -863.72% | 103.14% | -261.10% |
